Construction of Silver–Calcium Micro-Galvanic Cell on Titanium for Immunoregulation Osteogenesis
BME Frontiers · 2025-01 · 6
DOI: 10.34133/bmef.0173 ↗Kurz gefasst
Fachartikel in der Zeitschrift BME Frontiers, online erschienen am 08.09.2025. Verfasst von Zhenhao Hou und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of High Performance Ceramics, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: “Pioneer” and “Leading Goose” R&D Program of Zhejiang, the National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Objective
This work aims to construct a functional titanium surface with spontaneous electrical stimulation for immune osteogenesis and antibacteria. Impact Statement: A silver–calcium micro-galvanic cell was engineered on the titanium implant surface to spontaneously generate microcurrents for osteoimmunomodulation and bacteria killing, which provides a promising strategy for the design of a multifunctional electroactive titanium implant.
Introduction
Titanium-based implants are usually bioinert, which often leads to inflammation-induced loosening. Electrical stimulation has therapeutic potential; however, its dependence on external devices limits its clinical application. Therefore, designing an electroactive titanium surface with endogenous electrical stimulation capability is a promising strategy to overcome implant failure induced by inflammation.
Methods
The silver–calcium micro-galvanic cell was constructed on titanium substrate surfaces by the ion implantation technique. RAW264.7 and MC3T3-E1 were used for cell culture studies with the material to evaluate immunomodulatory and osteogenic abilities of the implant. The expression levels of inflammatory genes and voltage-gated Ca 2+ channel-related genes were tested for investigating the mechanism of immunoregulation. The antibacterial properties of the modified titanium were assessed. Finally, its immunomodulatory effects in vivo were verified by a mouse subcutaneous inflammation model.
Results
The silver–calcium micro-galvanic modified titanium surface generates microcurrents and releases Ca 2+ , which induces macrophage polarization toward the M2 phenotype and promotes osteogenic differentiation via paracrine signaling, exhibiting excellent antibacterial activity.
Conclusion
The silver–calcium micro-galvanic cell on titanium could regulate the immune response to promote bone repair and exhibit antibacterial capabilities through noninvasive electrical stimulation, providing a promising strategy for the design of multifunctional electroactive implant surfaces.
Autor:innen und Institutionen
- State Key Laboratory of High Performance Ceramics, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China.
- Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.
- School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
ORCID-Profile: Xuanyong Liu
Förderung
- “Pioneer” and “Leading Goose” R&D Program of Zhejiang
- the National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Hou, Z., Liu, X., Zhang, X., Tan, J., & Liu, X. (2025). Construction of Silver–Calcium Micro-Galvanic Cell on Titanium for Immunoregulation Osteogenesis. BME Frontiers, 6. https://doi.org/10.34133/bmef.0173
Vancouver
Hou Z, Liu X, Zhang X, Tan J, Liu X. Construction of Silver–Calcium Micro-Galvanic Cell on Titanium for Immunoregulation Osteogenesis. BME Frontiers. 2025;6. doi:10.34133/bmef.0173
BibTeX
@article{Hou2025,
author = {Hou, Zhenhao and Liu, Xingdan and Zhang, Xianming and Tan, Ji and Liu, Xuanyong},
title = {Construction of Silver–Calcium Micro-Galvanic Cell on Titanium for Immunoregulation Osteogenesis},
journal = {BME Frontiers},
year = {2025},
volume = {6},
doi = {10.34133/bmef.0173}
}
EUVIMED